Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/23/1993 | EP0547705A1 Pharmacologically active tricyclic benzotriazepine derivatives |
06/23/1993 | EP0547691A1 The use of 17B-N-mono-substituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones for the preparation of a medicament for the prevention of prostatic carcinoma |
06/23/1993 | EP0547690A1 Use of 17B-acyl-4-aza-5alpha-androst-1-en-3-ones for the preparation of a medicament for the prevention of prostatic carcinoma |
06/23/1993 | EP0547687A1 17B-N-Substituted adamantyl/norbonanyl carbamoyl-4-aza-5a-and-rost-1-en-3-ones and androstan-3 ones |
06/23/1993 | EP0547672A2 Inhibitors of farnesyl protein transferase |
06/23/1993 | EP0547671A2 Inhibitors of farnesyl protein transferase |
06/23/1993 | EP0547670A2 Inhibitors of farnesyl protein transferase |
06/23/1993 | EP0547669A2 Inhibitors of farnesyl protein transferase |
06/23/1993 | EP0547646A2 Crystalline form of a cephalosporin antibiotic |
06/23/1993 | EP0547558A1 Use of aminoguanidine for the manufacture of a medicament for inhibiting nitric oxide formation |
06/23/1993 | EP0547556A1 Substituted indole and benzimidazole derivatives useful as A-II receptors antagonists |
06/23/1993 | EP0547545A1 Pharmaceutical composition for the inhibition of bone resorption |
06/23/1993 | EP0547523A1 Ethanolates of 6-sulfonylsubstituted 3-hydroxychromanes and their use as inhalation means for illnesses |
06/23/1993 | EP0547517A1 Pyridyl derivatives, medicines containing these compounds and processes for their preparation |
06/23/1993 | EP0547514A2 Imidazopyridine derivatives with angiotensin-II antagonist properties |
06/23/1993 | EP0547508A1 Use of xanthine derivatives for the stabilisation of the auto-regulation of cerebral blood flow |
06/23/1993 | EP0547442A1 Dihydropyrimidin derivatives used as A-II receptor antagonists |
06/23/1993 | EP0547422A2 Stable powdery vitamin and/or carotinoid preparations and process for their production |
06/23/1993 | EP0547334A1 Combination of calcium antagonists with cholinesterase inhibitors for the treatment of senile demention |
06/23/1993 | EP0547294A1 Pharmaceutical compositions containing rifaximin for treatment of vaginal infections |
06/23/1993 | EP0547224A1 14-O-p-CHLOROBENZOYLACONINE AND ANALGESIC/ANTIINFLAMMATORY AGENT |
06/23/1993 | EP0547179A1 Triarylethylene carboxylic acids with estrogenic activity |
06/23/1993 | EP0547178A1 Novel cholecystokinin antagonists, their preparation and therapeutic use |
06/23/1993 | EP0547172A1 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
06/23/1993 | EP0547168A1 Certain cycloalkyl imidazopyrimidines, a new class of gaba brain receptor ligands |
06/23/1993 | EP0547165A1 Water soluble camptothecin analogues, processes and methods |
06/23/1993 | EP0547151A1 TREATMENT PROCESS FOR PROMOTING WEIGHT LOSS EMPLOYING A SUBSTITUTED $g(D)5-ANDROSTENE |
06/23/1993 | EP0547149A1 Inhibition of herpesviridae infection by antisense oligonucleotides |
06/23/1993 | EP0547148A1 Naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents |
06/23/1993 | EP0547145A1 Antiviral 2(1h)-quinolinone compounds |
06/23/1993 | EP0547140A1 Immunosuppressant composition |
06/23/1993 | EP0547126A1 Polymers containing diester units. |
06/23/1993 | EP0547104A1 Thiazolidin derivatives |
06/23/1993 | EP0547099A1 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa. |
06/23/1993 | EP0528978A4 Controlled release dopamine and its use to stimulate nerve fiber growth |
06/23/1993 | EP0348527B1 Antiallergic eye drop |
06/23/1993 | CN1073483A Fermented compound as insecticide and preparing process thereof |
06/23/1993 | CN1073449A Productive technology for extraction of Aralia chinensis saponin |
06/23/1993 | CN1073448A Oligo-deoxyribonucleotide with ischemia-resistant activity and its preparation |
06/23/1993 | CN1073447A Kedarcidin antitumor chromophore |
06/23/1993 | CN1073446A Substituted benzimidazoles, process for their preparation as well as their use |
06/23/1993 | CN1073444A Cephalosporin compounds and process for preparing the same |
06/23/1993 | CN1073443A O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity |
06/23/1993 | CN1073442A Method for preparing 3S,4R-N-oxalyl-3-ethyl-4-|1R-oxo-3S-thiolanylthio (thiocarbonyl)-thio¨-2-azetidinones |
06/23/1993 | CN1073439A Amorphous (quinolin-2-ylmethoxy) indoles |
06/23/1993 | CN1073437A Pharmaceutical compounds |
06/23/1993 | CN1073435A Continuous process for the manufacture of 2,5-dihydrofurans from gamma, delta-epoxybutenes |
06/23/1993 | CN1073433A Cyclohexaneacetic acid derivatives |
06/23/1993 | CN1073431A Compounds for treating leukotriene-related diseases |
06/23/1993 | CN1073430A Benzanilide derivatives |
06/23/1993 | CN1073428A Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses |
06/23/1993 | CN1073427A Mono-fluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase |
06/23/1993 | CN1073359A Lipophilic oligosaccharide antibiotics composite |
06/23/1993 | CN1073358A Improved freeze drying isocyclophosphamide composite |
06/23/1993 | CN1073357A Tocotrienols and tocotrienol-like compounds and methods for their use |
06/23/1993 | CN1073335A Air treatment plant for foodstuffs |
06/23/1993 | CN1021333C Process for preparing ganglioside derivatives |
06/23/1993 | CN1021328C Process for preparing pyridazinamine derivatives |
06/23/1993 | CN1021325C Process for preparing ethynylphenyl-containing retinoic acid derivatives |
06/23/1993 | CN1021323C Process for preparing antidepressants |
06/22/1993 | US5221943 Image forming apparatus |
06/22/1993 | US5221763 13,14-dihydro-15-keto-PGFs and salts |
06/22/1993 | US5221752 α-keto amide derivatives |
06/22/1993 | US5221741 Process for the preparation of 9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid hydrochloride |
06/22/1993 | US5221740 Oxepane isomers of rapamycin useful as immunosuppressive agents |
06/22/1993 | US5221695 Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin |
06/22/1993 | US5221690 Increasing the choroidal blood flow |
06/22/1993 | US5221688 Gastrointestinal disorders |
06/22/1993 | US5221687 Medicaments |
06/22/1993 | US5221683 Diaminopyridine compounds and methods of use |
06/22/1993 | US5221681 Vaso- and muscle-relaxants |
06/22/1993 | US5221679 Useful for those patient who had experienced inadequate clinical response or adverse effects from, clozapine and or neuroleptic drugs |
06/22/1993 | US5221678 Cardiovascular disorders, antiinflammatory agents, antiallergens |
06/22/1993 | US5221677 For treating diseases mediated by leukotrienes |
06/22/1993 | US5221672 Therapy for sleep disorders |
06/22/1993 | US5221669 Antiviral compositions containing α-cyclodextrin sulfates alone and in combination with other known antiviral agents and glucocorticoids and methods of treating viral infections |
06/22/1993 | US5221668 Partially digested protein and L-arginine |
06/22/1993 | US5221537 Tissue irrigating solutions |
06/22/1993 | US5221534 Health and beauty aid compositions |
06/22/1993 | CA1319365C 1,3,4-trisubstituted-1,3,4,5-tetrahydrobenzazepine-2-ones |
06/22/1993 | CA1319364C Fused heterocyclic compounds |
06/22/1993 | CA1319363C 3-demethyl-4-fluoromevalonic acid derivatives, a process for the preparation thereof, pharmaceutical products based on these compounds, the use thereof, and intermediates |
06/22/1993 | CA1319362C 4-substituted androstendione derivatives and process for their preparation |
06/22/1993 | CA1319323C Medicaments for the treatment of emesis |
06/22/1993 | CA1319322C Azelastine-containing medicaments for application in the nose and/or eye |
06/22/1993 | CA1319321C Pharmaceutical preparations |
06/21/1993 | WO1993013049A1 Using the immunoactivating activity of 3-naphthyloxy-2-hydroxy-propylamines, in particular for providing cell immunity, e.g. against viral infections |
06/21/1993 | CA2109224A1 Using the immunoactivating activity of 3-naphthyloxy-2-hydroxy-propylamines, in particular for providing cell immunity, e.g. against viral infections |
06/21/1993 | CA2085834A1 (1s) -hydroxyalkyl-oxapenem-3-carboxylic acids and their use as betalactamase inhibitors |
06/21/1993 | CA2085830A1 Ethylenically unsaturated bile acid derivatives, processes for their preparation and precursors |
06/21/1993 | CA2085819A1 Novel tricyclic steroid analogs |
06/21/1993 | CA2085716A1 Heterocyclically substituted carbamates and process for their preparation |
06/21/1993 | CA2085656A1 Benzodiazepine derivatives, compositions containing them and their use in therapy |
06/21/1993 | CA2085639A1 Lip treatment composition |
06/21/1993 | CA2085299A1 5-deaza-10-oxo- and 5-deaza-10-thio-5, 6, 7, 8-tetrahydrofolic acids |
06/21/1993 | CA2085297A1 Sulfonimidamides |
06/21/1993 | CA2084469A1 Antitumor compositions and methods of treatment |
06/21/1993 | CA2084442A1 Indole derivatives |
06/21/1993 | CA2083762A1 Methods of making 4" derivatives of 9-deoxo-8a-aza-8a- alkyl-8a-homoerythromycin a |
06/20/1993 | WO1993011753A1 Solvent system to be enclosed in capsules |